Reply to “CRISPR screens are feasible in TP53 wild‐type cells”

Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups. [Image: see text]

Detalles Bibliográficos
Autores principales: Haapaniemi, Emma, Botla, Sandeep, Persson, Jenna, Schmierer, Bernhard, Taipale, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686827/
https://www.ncbi.nlm.nih.gov/pubmed/31464368
http://dx.doi.org/10.15252/msb.20199059
_version_ 1783442633697263616
author Haapaniemi, Emma
Botla, Sandeep
Persson, Jenna
Schmierer, Bernhard
Taipale, Jussi
author_facet Haapaniemi, Emma
Botla, Sandeep
Persson, Jenna
Schmierer, Bernhard
Taipale, Jussi
author_sort Haapaniemi, Emma
collection PubMed
description Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups. [Image: see text]
format Online
Article
Text
id pubmed-6686827
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66868272019-08-13 Reply to “CRISPR screens are feasible in TP53 wild‐type cells” Haapaniemi, Emma Botla, Sandeep Persson, Jenna Schmierer, Bernhard Taipale, Jussi Mol Syst Biol Correspondence Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups. [Image: see text] John Wiley and Sons Inc. 2019-08-08 /pmc/articles/PMC6686827/ /pubmed/31464368 http://dx.doi.org/10.15252/msb.20199059 Text en © 2019 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Haapaniemi, Emma
Botla, Sandeep
Persson, Jenna
Schmierer, Bernhard
Taipale, Jussi
Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title_full Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title_fullStr Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title_full_unstemmed Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title_short Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
title_sort reply to “crispr screens are feasible in tp53 wild‐type cells”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686827/
https://www.ncbi.nlm.nih.gov/pubmed/31464368
http://dx.doi.org/10.15252/msb.20199059
work_keys_str_mv AT haapaniemiemma replytocrisprscreensarefeasibleintp53wildtypecells
AT botlasandeep replytocrisprscreensarefeasibleintp53wildtypecells
AT perssonjenna replytocrisprscreensarefeasibleintp53wildtypecells
AT schmiererbernhard replytocrisprscreensarefeasibleintp53wildtypecells
AT taipalejussi replytocrisprscreensarefeasibleintp53wildtypecells

Ejemplares similares